Cardlytics (CDLX) Enterprise Value (2016 - 2025)
Cardlytics (CDLX) has disclosed Enterprise Value for 10 consecutive years, with -$48.7 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Enterprise Value rose 25.73% year-over-year to -$48.7 million, compared with a TTM value of -$48.7 million through Dec 2025, up 25.73%, and an annual FY2025 reading of -$48.7 million, up 25.73% over the prior year.
- Enterprise Value was -$48.7 million for Q4 2025 at Cardlytics, down from -$44.0 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$44.0 million in Q3 2025 and bottomed at -$613.5 million in Q1 2021.
- Average Enterprise Value over 5 years is -$143.3 million, with a median of -$94.9 million recorded in 2023.
- The sharpest move saw Enterprise Value tumbled 500.49% in 2021, then skyrocketed 66.05% in 2022.
- Year by year, Enterprise Value stood at -$233.5 million in 2021, then surged by 47.78% to -$121.9 million in 2022, then grew by 24.67% to -$91.8 million in 2023, then grew by 28.57% to -$65.6 million in 2024, then grew by 25.73% to -$48.7 million in 2025.
- Business Quant data shows Enterprise Value for CDLX at -$48.7 million in Q4 2025, -$44.0 million in Q3 2025, and -$46.7 million in Q2 2025.